Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Children´s Clinic, Randers |
---|---|
Information provided by: | Children´s Clinic, Randers |
ClinicalTrials.gov Identifier: | NCT00236106 |
Main objective:to assess short term growth in children with atopic dermatitis during treatment with tacrolimus 0.1% and mometasone furoate 0.1%. A singl blind randomised cross over trial including 20 children. The study consists of 5 periods: run in, treatment(1),wash out, treatment(2) and run out. Each period 14 days where the children will use tacrolimus ointment tvice daily, mometasone furoate once daily or moisturizer (in run in wash out and run out)
Condition | Intervention | Phase |
---|---|---|
Atopic Dermatitis |
Drug: tacrolimus ointment 0.1% Drug: mometasone furoate 0.1% |
Phase IV |
Study Type: | Interventional |
Study Design: | Randomized, Single Blind, Active Control, Crossover Assignment, Safety Study |
Ages Eligible for Study: | 5 Years to 14 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria: age 5-14, atopic dermatitis, normal current growth, Tanner 1, informed consent by the parent or guardian, willing and able to comply with study procedures
Exclusion Criteria: Tanner 2-5, treatment of atopic dermatitis with anti-inflammatory agent within 1 week before the first visit, current asthma or rhinoconjunctivitis that requires treatment with glucocorticoids, endocrine diseases, major surgery within 4 weeks prior to visit 1, fever >39.5 for >3 days
Study ID Numbers: | BKR-AD-04 |
Study First Received: | October 7, 2005 |
Last Updated: | December 8, 2005 |
ClinicalTrials.gov Identifier: | NCT00236106 |
Health Authority: | Denmark: The Regional Committee on Biomedical Research Ethics; Denmark: Danish Dataprotection Agency; Denmark: Danish Medicines Agency |
Hypersensitivity Dermatitis, Atopic Genetic Diseases, Inborn Skin Diseases Mometasone furoate |
Hypersensitivity, Immediate Skin Diseases, Eczematous Tacrolimus Skin Diseases, Genetic Dermatitis |
Anti-Inflammatory Agents Immune System Diseases Therapeutic Uses Anti-Allergic Agents Pharmacologic Actions |